Riskpilot← Back to searchSign inGet full accessTandläkarhuset Lisbeth Nyander AB
ABDissolvedOrg 5590655626Other human health activities · NACE 8690Est. 20167 employees
Revenue 2019
SEK 11,2M
+10% vs 2018
EBITDA margin
27.3%
+22% vs 2018
Equity ratio
37.4%
Financial strength
Net profit 2019
SEK 831K
+144% vs 2018
| Revenue | SEK 11,2M | +10% |
| EBITDA | SEK 3M | +22% |
| Net profit | SEK 831K | +144% |
| Total assets | SEK 3,6M | +24% |
| Equity | SEK 1,3M | +165% |
| Employees | 7 | — |
Legal name
Tandläkarhuset Lisbeth Nyander AB
Org number
5590655626
Legal form
Aktiebolag
NACE code
8690 · Other human health activities
Founded
7 juni 2016
Share capital
SEK 0
Employees
7 (FTE)
VAT registered
No
Audit selected
No
Last report
2019-12-31
Financial year
January – December
Company purpose
Aktiebolaget ska bedriva tandläkarverksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|
| Revenue | 3 302 | 8 794 | 10 110 | 11 152 |
| Staff expenses | — | — | — | — |
| EBITDA | 1 500 | 2 264 | 2 503 | 3 046 |
| Depreciation & amort. | −189 | −417 | −504 | −463 |
| EBIT | 1 311 | 1 847 | 1 999 | 2 583 |
| Net financials | −14 | −24 | −2 | 374 |
| Profit before tax | 96 | 122 | 496 | 957 |
| Tax | −23 | −82 | −155 | −126 |
| Net profit | 73 | 40 | 341 | 831 |
| Item | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|
| Total assets | 3 015 | 3 809 | 2 884 | 3 568 |
| Equity | 123 | 163 | 505 | 1 336 |
| Long-term debt | 1 396 | 973 | 0 | 0 |
| Short-term debt | 1 495 | 2 673 | 2 380 | 2 232 |
| Total debt | 2 891 | 3 646 | 2 380 | 2 232 |
EBITDA margin
27.3%
This company
15.8%
Market median
+73% vs market
20162019
Equity ratio
37.4%
This company
38.2%
Market median
+2% vs market
20162019
Return on equity
62.2%
This company
18.4%
Market median
+238% vs market
20162019
Net profit margin
7.5%
This company
8.1%
Market median
-7% vs market
20162019
Asset turnover
3.13×
This company
1.12×
Market median
+179% vs market
20162019
Debt / equity
1.67×
This company
0.62×
Market median
-169% vs market
20162019
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-06-01 – 2016-12-31
| Name | Role | Member since |
|---|---|---|
| Former (3) | ||
SW Chief Auditor | Chief Auditor | 2020 – 2021 |
LC | Audit | 2020 – 2020 |
MB Chief Executive Officer | Chief Executive Officer | 2020 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Former (3) | ||
| Board of Directors | 2020 – 2020 | |
| Deputy Board Member | 2020 – 2021 | |
| Deputy Board Member | 2020 – 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Tandläkarhuset Lisbeth Nyander AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Susanne Westman | Chief Auditor | 0 companies |
| Liselotte Christina Cornell | Audit | 0 companies |
| Malin Birgitta Schmidt | Chief Executive Officer | 0 companies |
| Lisbeth Aasgaard Nyander | Board of Directors | 0 companies |
| Christopher Sebastian Östberg | Deputy Board Member | 0 companies |
| Lars Johan Nyander | Deputy Board Member | 0 companies |